Maccura Biotechnology Co.Ltd (SHE:300463)
China flag China · Delayed Price · Currency is CNY
12.15
+0.10 (0.83%)
Feb 4, 2026, 3:12 PM CST

SHE:300463 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Operating Revenue
2,1862,5252,8623,5683,9343,665
Other Revenue
23.3923.3933.9540.1846.4739.12
2,2092,5492,8963,6083,9813,704
Revenue Growth (YoY)
-19.03%-11.98%-19.75%-9.35%7.47%14.92%
Cost of Revenue
1,0481,1731,3841,7121,7401,796
Gross Profit
1,1611,3761,5121,8972,2401,908
Selling, General & Admin
804.11789.95805.79749.75756.1636.98
Research & Development
306.51323.15324.17273.22207.27202.07
Other Operating Expenses
23.1710.6511.7322.0228.7721.48
Operating Expenses
1,1561,1141,1801,081999.91880.9
Operating Income
5.47262.16331.6815.541,2401,027
Interest Expense
-22.12-22.12-33.53-35.06-59.27-68.19
Interest & Investment Income
7.199.3318.6224.155.44.33
Earnings From Equity Investments
-----0.99
Currency Exchange Gain (Loss)
0.160.161.115.33-2.19-4.5
Other Non Operating Income (Expenses)
7.44-1.41-2.383.2-3-4.73
EBT Excluding Unusual Items
-1.86248.12315.42813.171,181954.69
Impairment of Goodwill
-94.11-94.11----
Gain (Loss) on Sale of Investments
-0.562.15-7.08-9.1--
Gain (Loss) on Sale of Assets
1.81-6.73-4.17-4.12-4.050.94
Asset Writedown
-41.7-36.54-9.54-22.46-26.01-5.31
Other Unusual Items
-15.7111.7710.7311.5935.8119.44
Pretax Income
-152.13124.65305.37789.081,187969.77
Income Tax Expense
-30.825.890.6987.38184.88148.41
Earnings From Continuing Operations
-121.31118.76304.68701.711,002821.35
Minority Interest in Earnings
3.848.047.946.48-45.64-27.44
Net Income
-117.46126.81312.62708.18956.6793.92
Net Income to Common
-117.46126.81312.62708.18956.6793.92
Net Income Growth
--59.44%-55.86%-25.97%20.49%51.15%
Shares Outstanding (Basic)
610606609604553554
Shares Outstanding (Diluted)
610613612608557557
Shares Change (YoY)
-0.36%0.01%0.77%9.16%-0.11%-0.05%
EPS (Basic)
-0.190.210.511.171.731.43
EPS (Diluted)
-0.190.210.511.171.721.42
EPS Growth
--59.44%-56.19%-32.18%20.62%51.23%
Free Cash Flow
-308.37-329.2223.61-144.521,015592.73
Free Cash Flow Per Share
-0.51-0.540.04-0.241.821.06
Dividend Per Share
0.1040.1040.1540.3490.4710.431
Dividend Growth
-32.48%-32.48%-55.89%-25.86%9.30%127.83%
Gross Margin
52.58%53.99%52.20%52.57%56.28%51.51%
Operating Margin
0.25%10.29%11.45%22.60%31.16%27.72%
Profit Margin
-5.32%4.98%10.80%19.63%24.03%21.44%
Free Cash Flow Margin
-13.96%-12.92%0.81%-4.00%25.50%16.00%
EBITDA
344.02582.02626.551,0681,4631,232
EBITDA Margin
15.57%22.84%21.64%29.60%36.75%33.26%
D&A For EBITDA
338.54319.86294.94252.56222.54205.22
EBIT
5.47262.16331.6815.541,2401,027
EBIT Margin
0.25%10.29%11.45%22.60%31.16%27.72%
Effective Tax Rate
-4.72%0.23%11.07%15.57%15.30%
Revenue as Reported
2,2092,5492,8963,6083,9813,704
Advertising Expenses
-58.56104.6996.23114.7387.37
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.